Royalty Pharma plc (RPRX)

Growth

Revenue 5Y-6.16%
Revenue 3Y-10.06%
EPS 5Y-25.01%
EPS 3Y-38.10%
Dividend 5Y-28.67%
Dividend 3Y-43.06%

Capital Efficiency

ROIC5.70%
ROE8.54%
ROA2.87%
ROTA2.87%

Capital Structure

Market Cap17.08B
EV23.20B
Cash991.63M
Current Ratio2.07
Debt/Equity0.41
Net Debt/EBITDA6.85
Show More

Income Statement

Select a metric from the list below to chart it

Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
TTM
Income Statement
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
TTM
Revenue
1,577.5
1,658.9
1,794.6
2,122.4
2,289.5
2,247.2
Revenue % Chg.
-
5.2%
8.2%
18.3%
7.9%
-1.7%
Gross Profit
-
-
-
2,122.4
-
-
Gross Profit Margin
-
-
-
100.0%
-
-
R&D Expenses
117.9
392.6
83.0
26.3
200.1
230.4
R&D Expenses % Chg.
-
233.1%
-78.9%
-68.3%
661.1%
121.5%
Selling, General, & Admin Expenses
106.4
61.9
103.4
181.7
182.8
200.2
Selling, General, & Admin Expenses % Chg.
-
-41.8%
67.1%
75.7%
0.6%
-48.3%
Other Expenses
413.5
-160.0
-1,015.0
319.0
475.8
873.4
Other Expenses % Chg.
-
-
534.3%
-
49.2%
-
Operating Income
939.7
1,364.4
2,623.2
1,595.4
1,430.7
943.1
Operating Income % Chg.
-
45.2%
92.3%
-39.2%
-10.3%
-40.7%
Operating Income Margin
59.6%
82.2%
146.2%
75.2%
62.5%
42.0%
Operating Income Margin % Chg.
-
38.1%
77.7%
-48.6%
-16.9%
-39.7%
Total Other Income/Expenses Net
403.5
153.4
-161.8
106.6
-189.5
-49.4
Total Other Income/Expenses Net % Chg.
-
-62.0%
-
-
-
32.7%
Income Before Tax
1,343.2
1,517.9
2,461.4
1,702.0
1,241.2
893.8
Income Before Tax % Chg.
-
13.0%
62.2%
-30.9%
-27.1%
-42.5%
Income Before Tax Margin
85.1%
91.5%
137.2%
80.2%
54.2%
39.8%
Income Before Tax Margin % Chg.
-
7.5%
49.9%
-41.5%
-32.4%
-41.5%
Net Income
1,210.0
1,377.7
2,348.5
975.0
619.7
506.8
Net Income % Chg.
-
13.9%
70.5%
-58.5%
-36.4%
-35.3%
Net Income Margin
76.7%
83.0%
130.9%
45.9%
27.1%
22.6%
Net Income Margin % Chg.
-
8.3%
57.6%
-64.9%
-41.1%
-34.1%
Weighted Avg. Shares Out
354.2
354.2
354.2
388.1
671.8
434.4
Weighted Avg. Shares Out % Chg.
-
-
-
9.6%
73.1%
7.6%
EPS
3.4
3.9
3.4
2.5
0.9
1.2
EPS % Chg.
-
13.9%
-13.9%
-25.0%
-63.3%
-40.3%
Weighted Avg. Shares Out Dil
354.2
354.2
354.2
388.1
671.8
607.2
Weighted Avg. Shares Out Dil % Chg.
-
-
-
9.6%
73.1%
9.9%
EPS Diluted
3.4
3.9
3.4
2.5
0.9
1.2
EPS Diluted % Chg.
-
13.9%
-13.9%
-25.0%
-63.3%
-40.6%
Interest Income
6.8
24.4
22.3
28.4
53.5
45.1
Interest Income % Chg.
-
261.4%
-8.6%
27.1%
88.6%
-29.6%
Interest Expense
247.3
280.0
268.6
157.1
166.1
188.0
Interest Expense % Chg.
-
13.2%
-4.1%
-41.5%
5.8%
19.7%
EBIT
1,102.6
1,262.3
2,215.2
1,573.3
1,128.6
750.9
EBIT % Chg.
-
14.5%
75.5%
-29.0%
-28.3%
-48.6%
EBIT Margin
69.9%
76.1%
123.4%
74.1%
49.3%
33.4%
EBIT Margin % Chg.
-
8.9%
62.2%
-39.9%
-33.5%
-47.7%
Depreciation & Amortization
33.3
33.3
23.9
23.1
23.0
-
Depreciation & Amortization % Chg.
-
-
-28.1%
-3.6%
-0.3%
-
EBITDA
1,135.9
1,295.6
2,239.1
1,596.3
1,151.6
750.9
EBITDA % Chg.
-
14.1%
72.8%
-28.7%
-27.9%
-49.2%
EBITDA Margin
72.0%
78.1%
124.8%
75.2%
50.3%
33.4%
EBITDA Margin % Chg.
-
8.5%
59.8%
-39.7%
-33.1%
-48.3%